U-Chart Analysis:ZERIA PHARMACEUTICAL CO.,LTD.:4559

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ZERIA PHARMACEUTICAL CO.,LTD. Go to web site 4559 Medicals 東証プライム March 1, 2000 1998.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2025年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 23,593 20,324 16,219 11,704 9,794
Other Current AssetsHelp 45,937 37,485 31,985 29,959 27,520
Tangible Fixed AssetsHelp 26,641 26,518 24,591 23,139 23,634
Intangible Fixed AssetHelp 8,790 9,380 8,473 7,836 7,690
Investments and OthersHelp 22,639 23,067 20,309 18,273 18,842
Total AssetsHelp 159,172 150,534 135,035 124,282 121,860
Total Current LiabilitiesHelp 62,766 62,967 55,043 51,002 60,056
Total Long-term LiabilitiesHelp 6,866 7,944 14,541 18,386 5,820
Shareholder's EquityHelp 89,540 79,623 65,450 54,895 55,985
Total LiabilitiesHelp 159,172 150,534 135,035 124,282 121,860

ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2025年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 87,311 75,725 68,383 59,533 55,442
Total Sales 87,311 75,725 68,383 59,533 55,442
Cost of SalesHelp 23,351 20,224 18,895 17,385 15,796
Other Costs and RevenueHelp 54,023 47,770 43,293 38,187 36,502
Total CostsHelp 77,375 67,994 62,187 55,572 52,299
Net RevenueHelp 63,960 55,501 49,489 42,148 39,646
Earnings Before TaxHelp 12,619 9,508 7,273 5,722 3,957
Net IncomeHelp 9,936 7,731 6,196 3,961 3,143
Net Income 9,936 7,731 6,196 3,961 3,143

ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2025年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 12,922 12,184 13,157 9,080 6,894
Investing Cash Flow(ICF)Help -1,051 -3,952 -2,575 -2,893 -17,461
Financing Cash FlowHelp -7,757 -8,124 -7,415 -4,841 11,185
Exchange Difference of Cash and Cash EquivalentsHelp 749 2,403 1,347 564 170
Net Increase and Decrease in Cash and Cash Equivalentsn 4,864 2,510 4,515 1,910 789

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ZERIA PHARMACEUTICAL CO.,LTD.
T.RAD Co., Ltd.
Denyo Co.,Ltd.

Company where related level is highHelp

ASKA Pharmaceutical Holdings Co., Ltd.
Tsubota Laboratory Incorporated
DAIICHI SANKYO COMPANY, LIMITED
MIZUHO MEDY CO.,LTD.
Cuorips Inc.
Sumitomo Pharma Co., Ltd.
Chordia Therapeutics
CanBas Co.,Ltd.
TORII PHARMACEUTICAL CO.,LTD.
Eisai Co.,Ltd.